Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2012, Article ID 850684, 13 pages
http://dx.doi.org/10.1155/2012/850684
Research Article

Preventive Effects of Epigallocatechin-3-O-Gallate against Replicative Senescence Associated with p53 Acetylation in Human Dermal Fibroblasts

1Department of Applied Nanoscience and BK 21 Nano Fusion Technology Division, College of Nanoscience & Nanotechnology, Pusan National University, San 30 Jangjeon-dong, Geumjeong-gu, Busan 609-735, Republic of Korea
2Cellbiocontrol Laboratory, Department of Medical Engineering, Yonsei University College of Medicine, 134 Shinchon-dong, Seodaemun-gu, Seoul 120-752, Republic of Korea
3Center for Innovation in Immunoregulative Technology and Therapeutics, Kyoto University Graduate School of Medicine, Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan
4Department of Biobased Materials Science, Kyoto Institute of Technology, Matsugasaki, Sakyo-ku, Kyoto 606-8585, Japan

Received 19 July 2012; Revised 17 September 2012; Accepted 8 October 2012

Academic Editor: Gabriele Saretzki

Copyright © 2012 Dong-Wook Han et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Hayflick and P. S. Moorhead, “The serial cultivation of human diploid cell strains,” Experimental Cell Research, vol. 25, no. 3, pp. 585–621, 1961. View at Google Scholar · View at Scopus
  2. M. Collado, M. A. Blasco, and M. Serrano, “Cellular senescence in cancer and aging,” Cell, vol. 130, no. 2, pp. 223–233, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. S.-J. Park, F. Ahmad, A. Philp et al., “Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases,” Cell, vol. 148, no. 3, pp. 421–433, 2012. View at Publisher · View at Google Scholar
  4. J. S. Allard, E. Perez, S. Zou, and R. de Cabo, “Dietary activators of Sirt1,” Molecular and Cellular Endocrinology, vol. 299, no. 1, pp. 58–63, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. M. V. Blagosklonny, “An anti-aging drug today: from senescence-promoting genes to anti-aging pill,” Drug Discovery Today, vol. 12, no. 5-6, pp. 218–224, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. K. T. Howitz, K. J. Bitterman, H. Y. Cohen et al., “Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan,” Nature, vol. 425, no. 6954, pp. 191–196, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. J. C. Mak, “Potential role of green tea catechins in various disease therapies: progress and promise,” Clinical and Experimental Pharmacology and Physiology, vol. 39, no. 3, pp. 265–273, 2012. View at Publisher · View at Google Scholar
  8. S. Ahmed, “Green tea polyphenol epigallocatechin 3-gallate in arthritis: progress and promise,” Arthritis Research and Therapy, vol. 12, no. 2, article 208, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. K. B. Pandey and S. I. Rizvi, “Plant polyphenols as dietary antioxidants in human health and disease,” Oxidative Medicine and Cellular Longevity, vol. 2, no. 5, pp. 270–278, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. M. E. Obrenovich, N. G. Nair, A. Beyaz, G. Aliev, and V. P. Reddy, “The role of polyphenolic antioxidants in health, disease, and aging,” Rejuvenation Research, vol. 13, no. 6, pp. 631–643, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. B. L. Queen and T. O. Tollefsbol, “Polyphenols and aging,” Current Aging Science, vol. 3, no. 1, pp. 34–42, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. J. A. Kim, “Mechanisms underlying beneficial health effects of tea catechins to improve insulin resistance and endothelial dysfunction,” Endocrine, Metabolic and Immune Disorders, vol. 8, no. 2, pp. 82–88, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Bulku, D. Zinkovsky, P. Patel et al., “A novel dietary supplement containing multiple phytochemicals and vitamins elevates hepatorenal and cardiac antioxidant enzymes in the absence of significant serum chemistry and genomic changes,” Oxidative Medicine and Cellular Longevity, vol. 3, no. 2, pp. 129–144, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. S. A. Mandel, T. Amit, O. Weinreb, and M. B. H. Youdim, “Understanding the broad-spectrum neuroprotective action profile of green tea polyphenols in aging and neurodegenerative diseases,” Journal of Alzheimer's Disease, vol. 25, no. 2, pp. 187–208, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. V. Stangl, M. Lorenz, and K. Stangl, “The role of tea and tea flavonoids in cardiovascular health,” Molecular Nutrition and Food Research, vol. 50, no. 2, pp. 218–228, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. M. K. Shanmugam, R. Kannaiyan, and G. Sethi, “Targeting cell signaling and apoptotic pathways by dietary agents: role in the prevention and treatment of cancer,” Nutrition and Cancer, vol. 63, no. 2, pp. 161–173, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. M. H. Pan, C. S. Lai, S. Dushenkov, and C. T. Ho, “Modulation of inflammatory genes by natural dietary bioactive compounds,” Journal of Agricultural and Food Chemistry, vol. 57, no. 11, pp. 4467–4477, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Y. Bae, J. Kanamune, D. W. Han, K. Matsumura, and S. H. Hyon, “Reversible regulation of cell cycle-related genes by epigallocatechin gallate for hibernation of neonatal human tarsal fibroblasts,” Cell Transplantation, vol. 18, no. 4, pp. 459–469, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. H. H. Cho, D. W. Han, K. Matsumura, S. Tsutsumi, and S. H. Hyon, “The behavior of vascular smooth muscle cells and platelets onto epigallocatechin gallate-releasing poly(l-lactide-co-ε-caprolactone) as stent-coating materials,” Biomaterials, vol. 29, no. 7, pp. 884–893, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Y. Bae, D. W. Han, K. Matsumura, S. Wakitani, M. Nawata, and S. H. Hyon, “Nonfrozen preservation of articular cartilage by epigallocatechin-3-gallate reversibly regulating cell cycle and nf-κB expression,” Tissue Engineering A, vol. 16, no. 2, pp. 595–603, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. D. W. Han, M. H. Lee, H. H. Kim, S. H. Hyon, and J. C. Park, “Epigallocatechin-3-gallate regulates cell growth, cell cycle and phosphorylated nuclear factor-κB in human dermal fibroblasts,” Acta Pharmacologica Sinica, vol. 32, no. 5, pp. 637–646, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Marcotte, C. Lacelle, and E. Wang, “Senescent fibroblasts resist apoptosis by downregulating caspase-3,” Mechanisms of Ageing and Development, vol. 125, no. 10-11, pp. 777–783, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. D. W. Han, K. Matsumura, B. Kim, and S. H. Hyon, “Time-dependent intracellular trafficking of FITC-conjugated epigallocatechin-3-O-gallate in L-929 cells,” Bioorganic and Medicinal Chemistry, vol. 16, no. 22, pp. 9652–9659, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. Q. Meng, C. N. Velalar, and R. Ruan, “Effects of epigallocatechin-3-gallate on mitochondrial integrity and antioxidative enzyme activity in the aging process of human fibroblast,” Free Radical Biology and Medicine, vol. 44, no. 6, pp. 1032–1041, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. I. Ben-Porath and R. A. Weinberg, “When cells get stressed: an integrative view of cellular senescence,” Journal of Clinical Investigation, vol. 113, no. 1, pp. 8–13, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. J. H. Lee, K. Y. Chung, D. Bang, and K. H. Lee, “Searching for aging-related proteins in human dermal microvascular endothelial cells treated with anti-aging agents,” Proteomics, vol. 6, no. 4, pp. 1351–1361, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. V. J. Cristofalo, P. D. Phillips, T. Sorger, and G. Gerhard, “Alterations in the responsiveness of senescent cells to growth factors,” Journals of Gerontology, vol. 44, no. 6, pp. 55–62, 1989. View at Google Scholar · View at Scopus
  28. V. Dulic, L. F. Drullinger, E. Lees, S. I. Reed, and G. H. Stein, “Altered regulation of G1 cyclins in senescent human diploid fibroblasts: accumulation of inactive cyclin E-Cdk2 and cyclin D1-Cdk2 complexes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 23, pp. 11034–11038, 1993. View at Publisher · View at Google Scholar · View at Scopus
  29. J. P. Brown, W. Wei, and J. M. Sedivy, “Bypass of senescenoe after disruption of p21(CIP1)/(WAF1) gene in normal diploid human fibroblasts,” Science, vol. 277, no. 5327, pp. 831–834, 1997. View at Publisher · View at Google Scholar · View at Scopus
  30. G. H. Stein, L. F. Drullinger, R. S. Robetorye, O. M. Pereira-Smith, and J. R. Smith, “Senescent cells fail to express cdc2, cycA, and cycB in response to mitogen stimulation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 24, pp. 11012–11016, 1991. View at Google Scholar · View at Scopus
  31. M. H. Lee, D. W. Han, S. H. Hyon, and J. C. Park, “Apoptosis of human fibrosarcoma HT-1080 cells by epigallocatechin-3-O-gallate via induction of p53 and caspases as well as suppression of Bcl-2 and phosphorylated nuclear factor-κB,” Apoptosis, vol. 16, no. 1, pp. 75–85, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Kume, M. Haneda, K. Kanasaki et al., “Silent information regulator 2 (SIRT1) attenuates oxidative stress-induced mesangial cell apoptosis via p53 deacetylation,” Free Radical Biology and Medicine, vol. 40, no. 12, pp. 2175–2182, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Y. Cohen, C. Miller, K. J. Bitterman et al., “Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase,” Science, vol. 305, no. 5682, pp. 390–392, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. B. K. Kennedy, K. K. Steffen, and M. Kaeberlein, “Ruminations on dietary restriction and aging,” Cellular and Molecular Life Sciences, vol. 64, no. 11, pp. 1323–1328, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Pallàs, E. Verdaguer, M. Tajes, J. Gutierrez-Cuesta, and A. Camins, “Modulation of sirtuins: New targets for antiageing,” Recent Patents on CNS Drug Discovery, vol. 3, no. 1, pp. 61–69, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Srivastava and M. C. Haigis, “Role of sirtuins and calorie restriction in neuroprotection: implications in Alzheimer’s and Parkinson’s diseases,” Current Pharmaceutical Design, vol. 17, no. 31, pp. 3418–3433, 2011. View at Publisher · View at Google Scholar
  37. G. S. Kelly, “A review of the sirtuin system, its clinical implications, and the potential role of dietary activators like resveratrol: part 2,” Alternative Medicine Review, vol. 15, no. 4, pp. 313–328, 2010. View at Google Scholar · View at Scopus
  38. R. F. Loeser, “Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix,” Osteoarthritis and Cartilage, vol. 17, no. 8, pp. 971–979, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. J. A. Martin and J. A. Buckwalter, “Aging, articular cartilage chondrocyte senescence and osteoarthritis,” Biogerontology, vol. 3, no. 5, pp. 257–264, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. Y. Wang, A. Meng, and D. Zhou, “Inhibition of phosphatidylinostol 3-kinase uncouples H2O2-induced senescent phenotype and cell cycle arrest in normal human diploid fibroblasts,” Experimental Cell Research, vol. 298, no. 1, pp. 188–196, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Furukawa, S. Tada-Oikawa, S. Kawanishi, and S. Oikawa, “H2O2 accelerates cellular senescence by accumulation of acetylated p53 via decrease in the function of SIRT1 by NAD+ depletion,” Cellular Physiology and Biochemistry, vol. 20, no. 1–4, pp. 45–54, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. I. Afanas'ev, “Reactive oxygen species and age-related genes p66shc, Sirtuin, FOX03 and Klotho in senescence.,” Oxidative medicine and cellular longevity, vol. 3, no. 2, pp. 77–85, 2010. View at Google Scholar · View at Scopus
  43. S. Okabe, M. Suganuma, M. Hayashi, E. Sueoka, A. Komori, and H. Fujiki, “Mechanisms of growth inhibition of human lung cancer cell line, PC-9, by tea polyphenols,” Japanese Journal of Cancer Research, vol. 88, no. 7, pp. 639–643, 1997. View at Google Scholar · View at Scopus
  44. J. Hong, H. Lu, X. Meng, J. H. Ryu, Y. Hara, and C. S. Yang, “Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (-)-epigallocatechin-3-gallate in HT-29 human colon adenocarcinoma cells,” Cancer Research, vol. 62, no. 24, pp. 7241–7246, 2002. View at Google Scholar · View at Scopus
  45. H. Tachibana, K. Koga, Y. Fujimura, and K. Yamada, “A receptor for green tea polyphenol EGCG,” Nature Structural and Molecular Biology, vol. 11, no. 4, pp. 380–381, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. J. D. Lambert, M. J. Lee, H. Lu et al., “Epigallocatechin-3-Gallate is absorbed but extensively glucuronidated following oral administration to mice,” Journal of Nutrition, vol. 133, no. 12, pp. 4172–4177, 2003. View at Google Scholar · View at Scopus